-Reuters
Gilead Sciences Q2 EPS $1.58 Beats $1.53 Estimate
Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.53 by 3.27 percent. This is a 15.51 percent decrease over earnings of $1.87 per share from the